We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives. THE THIRD ROCK TEAM Our team has a proven record of translating disruptive technologies into valuable business enterprises. Working closely with leading scientific and business visionaries as well as industry partners, we identify opportunities to change the future of medicine and rigorously vet those ideas through our discovery process to develop the vision, strategy and plan needed to succeed. A FORMULA FOR INNOVATION We only invest in the best of those ideas. We are actively involved in the early stages of our companies’ development, typically serving as members of the founding management teams, to build a strong foundation, put in place the right people and culture, and set the companies on a path to scientific and operational excellence. We believe in the companies we launch and make big initial investments, often complemented by strategic alliances, to enable our companies to advance life-changing therapies, devices and diagnostics. By creating value for patients, we create value for our investors.
Looking for a particular Third Rock Ventures employee's phone or email?
The Third Rock Ventures annual revenue was $27 million in 2026.
Kevin Gillis is the COO and Partner of Third Rock Ventures.
79 people are employed at Third Rock Ventures.
Third Rock Ventures is based in Boston, Massachusetts.
The NAICS codes for Third Rock Ventures are [52, 523, 5239].
The SIC codes for Third Rock Ventures are [679, 67].